Home Mf Research Whiteoak Capital Pharma And Healthcare Fund Regular Plan Growth

Whiteoak Capital Pharma and Healthcare Fund - Regular Plan - Growth

-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • SI
Fund info
NAV (as on 2025-07-18)
13.86 -0.48%
AUM (Fund Size)
N/A
Expense Ratio
2.37%
Exit load
1.00%
Risk
N/A
AMC
WhiteOak Capital Mutual Fund
View AMC Details

SIP Returns

Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-07-11 ₹1,000.00 ₹1,019.65
1.96 %
Two Week 2025-07-03 ₹1,000.00 ₹1,017.63
1.76 %
One Month 2025-06-18 ₹1,000.00 ₹1,050.82
5.08 %
Three Months 2025-04-21 ₹3,000.00 ₹3,216.37
7.21 %
Six Months 2025-01-20 ₹6,000.00 ₹6,484.14
8.07 %
One Year 2024-07-18 ₹12,000.00 ₹13,148.46
9.57 %
Since Inception 2024-01-16 ₹19,000.00 ₹22,429.44
18.05 %

Return Calculator

SIP Amount
1M
6M
1Y
3Y
5Y
Investment
₹0
Maturity Value
₹0
Abs. Returns
0
Current CAGR
0

Portfolio

Allocation of Equity and Debt Asset Classes.

Equity N/A
Debt N/A
Others N/A

Sectors Holding in Whiteoak Capital Pharma and Healthcare Fund - Regular Plan - Growth

Pharmaceuticals & Biotechnology
57%
Healthcare Services
11%
Healthcare Equipment & Supplies
2%
Chemicals & Petrochemicals
0%
Unknown
13%

Companies Holding in Whiteoak Capital Pharma and Healthcare Fund - Regular Plan - Growth

Sun Pharmaceutical Industries Limited
7.02%
Cipla Limited
4.59%
Divi's Laboratories Limited
4.97%
Zydus Lifesciences Limited
5.36%
Lupin Limited
2.30%
Torrent Pharmaceuticals Limited
4.07%
Dr. Reddy's Laboratories Limited
3.40%
Aurobindo Pharma Limited
3.14%
Emcure Pharmaceuticals Limited
3.24%
Glenmark Pharmaceuticals Limited
3.11%
Ajanta Pharma Limited
3.04%
Max Healthcare Institute Limited
2.78%
Krishna Institute Of Medical Sciences Limited
2.66%
Neuland Laboratories Limited
2.66%
Poly Medicure Limited
2.65%
Fortis Healthcare Limited
2.58%
Vijaya Diagnostic Centre Limited
2.42%
Biocon Limited
2.28%
Piramal Pharma Limited
1.91%
Dr. Lal Path Labs Limited
1.89%
Gland Pharma Limited
1.82%
Shilpa Medicare Limited
1.69%
AstraZeneca Pharma India Limited
1.64%
Wockhardt Limited
1.63%
Ami Organics Limited
1.55%
RPG Life Sciences Limited
1.43%
Jupiter Life Line Hospitals Limited
1.38%
Suven Pharmaceuticals Limited
1.33%
FDC Limited
1.16%
Apollo Hospitals Enterprise Limited
1.11%
Supriya Lifescience Limited
1.08%
Granules India Limited
1.02%
Gufic Biosciences Limited
1.01%
Strides Pharma Science Limited
0.96%
Sanofi Consumer Healthcare India Limited
0.75%
Indegene Limited
0.74%
Innova Captab Limited
0.67%
Neogen Chemicals Limited
0.53%
Mankind Pharma Limited
0.19%
Treasury Bill
2.74%
364 Days Sovereign
1.38%
182 Days Sovereign
1.01%
91 Days Sovereign
0.35%
TREPS
8.31%
Net Receivables / (Payables)
1.19%

Risk Ratios

Std. Deviation N/A
Beta N/A
Sharpe Ratio N/A
Lock In Period N/A
Residual Maturity N/A

Standard Deviation:

Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.

Beta:

Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.

Sharpe Ratio:

The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.

Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.

Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.

Scheme Details

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio Regular
2.37
Expense Ratio Direct
0.65
Lock-in Period
N/A
Fund Age
N/A
Benchmark
N/A
Fund managers
Mr. Ramesh Mantri
Over 20 Years Experience
Mr. Dheeresh Pathak
Over 16 Years Experience
Mr. Piyush Baranwal
Over 14 Years Experience

Exit load

1.00%

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?